Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.64 -0.16 (-0.85%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Revenue (2010 - 2026)

Updated

Sarepta Therapeutics (SRPT) posted Revenue of $401.25 million for Q2 2026, down 34.3% from $611.09 million a year earlier and down 45.1% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Revenue (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Sarepta Therapeutics was $1.97 billion, down 20.4% year-over-year; for FY2025, it was $2.2 billion, up 15.6% from FY2024.

  • Annual Revenue has increased for eight consecutive years, with a five-year compound annual growth rate of 32.4% (FY2020 to FY2025).
  • In prior years, Sarepta Therapeutics' Revenue was $1.9 billion in FY2024 (+53.0%), $1.24 billion in FY2023 (+33.3%), $933.01 million in FY2022 (+32.9%) and $701.89 million in FY2021 (+30.0%).
  • Quarterly Revenue has run from a low of $189.41 million in Q3 2021 to a high of $744.86 million in Q1 2025 over five years.
  • On a year-over-year basis, Revenue has declined in each of the last four quarters, with growth averaging 21.5% over the last eight quarters.
  • The strongest year-over-year quarter for Revenue in the past five years was Q1 2025, with growth of 80.2%; the weakest was Q2 2026, with a decline of 34.3%.
  • According to Business Quant data, Revenue for the three prior quarters was $730.8 million (Q1 2026), $442.93 million (Q4 2025) and $399.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Sarepta Therapeutics 1.99 Bn -1.25 Bn 251.87 Mn 401.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 401.25 Mn
Mar 31, 2026 730.80 Mn
Dec 31, 2025 442.93 Mn
Sep 30, 2025 399.36 Mn
Jun 30, 2025 611.09 Mn
Mar 31, 2025 744.86 Mn
Dec 31, 2024 658.41 Mn
Sep 30, 2024 467.17 Mn
Jun 30, 2024 362.93 Mn
Mar 31, 2024 413.46 Mn
Dec 31, 2023 396.78 Mn
Sep 30, 2023 331.82 Mn
Jun 30, 2023 261.24 Mn
Mar 31, 2023 253.50 Mn
Dec 31, 2022 258.43 Mn
Sep 30, 2022 230.27 Mn
Jun 30, 2022 233.49 Mn
Mar 31, 2022 210.83 Mn
Dec 31, 2021 201.46 Mn
Sep 30, 2021 189.41 Mn
API Access

Sarepta Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=SRPT&period=max&api_key=YOUR_API_KEY